Beryl Drugs Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE415H01017 52Wk High (Rs.) 30 BV (Rs.) 18.30 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 16 EPS (Rs.) 1.14 P/E (X) 16.13
Mkt Cap. (Rs. Cr.) 9.33 P/BV (X) 1.01 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsDec 25Sep 25Jun 25Mar 25Dec 24
Net Sales/Income from operations3.785.124.793.975.31
Total Income From Operations3.785.124.793.975.31
      
EXPENDITURE     
Consumption of Raw Materials2.082.792.212.462.63
Increase/Decrease in Stocks-0.05-0.21-0.180.35-0.79
Employees Cost0.790.580.530.590.62
Depreciation0.320.390.380.320.31
Other Expenses1.221.271.731.312.36
Total Expenses4.374.824.675.045.12
      
P/L Before Other Inc. , Int., Excpt. Items & Tax-0.590.300.13-1.070.19
Other Income0.070.040.041.250.09
P/L Before Interest, Excpt. Items & Tax-0.520.340.170.180.28
Interest0.090.080.100.080.12
P/L Before Exceptional Items & Tax-0.610.260.070.100.16
P/L Before Tax-0.610.260.070.100.16
Tax-0.440.250.05-0.050.11
P/L After Tax from Ordinary Activities-0.170.010.020.150.05
Net Profit/Loss For the Period-0.170.010.020.150.05
      
Equity Share Capital5.075.075.075.075.07
EPS Before Extra Ordinary *     
Basic EPS (Rs.)-0.330.020.040.300.10
Diluted EPS (Rs.)-0.330.020.040.300.10
EPS After Extra Ordinary *     
Basic EPS (Rs.) -0.330.020.040.300.10
Diluted EPS (Rs.) -0.330.020.040.300.10
      
PBITOE Margin (%)-15.615.932.69-26.803.53
PBTE Margin (%)-16.095.081.452.563.02
PBT Margin (%)-16.095.081.452.563.02
PAT Margin (%)-4.440.170.443.820.98